Bio-Rad Laboratories, Inc. (NYSE:BIO – Get Rating) shares saw unusually-high trading volume on Monday . Approximately 64,548 shares changed hands during mid-day trading, a decline of 64% from the previous session’s volume of 177,345 shares.The stock last traded at $383.72 and had previously closed at $382.14. Analysts Set New Price Targets BIO has been the […]
Bio-Rad Laboratories, Inc. (NYSE:BIO – Get Rating) was the recipient of a large decline in short interest during the month of April. As of April 30th, there was short interest totalling 236,400 shares, a decline of 13.8% from the April 15th total of 274,400 shares. Currently, 1.1% of the company’s shares are sold short. Based […]
WASHINGTON TRUST Co lifted its stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO – Get Rating) by 62.5% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 78 shares of the medical research company’s stock after purchasing an additional 30 shares during […]
FORA Capital LLC raised its holdings in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO – Get Rating) by 34.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,569 shares of the medical research company’s stock after buying an additional 400 shares during […]
Russell Investments Group Ltd. cut its stake in Bio-Rad Laboratories, Inc. (NYSE:BIO – Get Rating) by 11.1% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 60,365 shares of the medical research company’s stock after selling 7,564 shares during the period. Russell Investments Group […]